Skip to main content
In stock | Immunotherapy (Monoclonal Antibody)

Ofatumumab

Oncology Type Hematologic (Lymphoma/CLL)
Drug Class / Mechanism Anti-CD20 mAb
No Image
Description

Ofatumumab is classified as an Anti-CD20 mAb, sourced for use within our Immunotherapy (Monoclonal Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Immunotherapy (Monoclonal Antibody)
Oncology Type Hematologic (Lymphoma/CLL)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3